vancomycin has been researched along with virginiamycin in 146 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (5.48) | 18.7374 |
1990's | 68 (46.58) | 18.2507 |
2000's | 51 (34.93) | 29.6817 |
2010's | 17 (11.64) | 24.3611 |
2020's | 2 (1.37) | 2.80 |
Authors | Studies |
---|---|
Avril, JL; Lissac, J | 1 |
Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
Nishino, T | 1 |
Baillie, L; Casewell, M; Rolando, N; Wade, J | 1 |
Chambers, HF | 1 |
Goto, S; Kaneko, Y; Miyazaki, S | 1 |
Verbist, L; Verhaegen, J | 1 |
Bouanchaud, DH; Huet, Y; Rolin, O | 1 |
Maskell, JP; Williams, JD | 1 |
Cancet, B; Clave, D; Didier, J; Henry-Ferry, S; Marty, N | 1 |
Chi, SJ; Maskell, JP; Sefton, AM; Williams, JD; Yong, J | 1 |
Beck, D; Siegenthaler, G; Siegenthaler, W; Weidmann, P | 1 |
Hohenegger, M; Hromadka, A | 1 |
Lecaillon-Thibon, E; Messmer, JC; Soler, H | 1 |
Drugeon, H; Entenza, JM; Glauser, MP; Moreillon, P | 1 |
Entenza, JM; Glauser, MP; L'Hériteau, F; Lacassin, F; Leport, C; Moreillon, P | 1 |
Kang, SL; Rybak, MJ | 2 |
Carbon, C; Duval, J; Fantin, B; Leclercq, R; Merlé, Y; Saint-Julien, L; Veyrat, C | 1 |
Cooper, B; Freeman, C; Mazens-Sullivan, M; Nightingale, C; Quintiliani, R; Robinson, A | 1 |
Appelbaum, PC; Jacobs, MR; Pankuch, GA | 2 |
Carbon, C; Duval, J; Fantin, B; Leclercq, R; Maziere, B; Ottaviani, M; Pocidalo, JJ; Vallois, JM | 1 |
Collins, LA; Eliopoulos, GM; Ferraro, MJ; Malanoski, GJ; Moellering, RC; Wennersten, CB | 1 |
Berthaud, N; Conard, BJ; Desnottes, JF; Montay, G | 1 |
Millichap, J; Noskin, GA; Peterson, LR; Ristow, TA | 1 |
Herrera-Insúa, I; Jacques-Palaz, K; Murray, BE; Rakita, RM | 1 |
Zervos, M | 1 |
Furness, KM; Holloway, WJ; Johnson, JA; Johnson, RJ; McIntosh, AC; Qaiyumi, S; Schwalbe, RS; Steele-Moore, L | 1 |
Cormican, MG; Johnson, DM; Jones, RN | 1 |
Chow, JW; Donahedian, SM; Zervos, MJ | 1 |
Chow, JW; Davidson, A; Sanford, E; Zervos, MJ | 1 |
Garcia, R; Raad, I | 1 |
Handwerger, S; Mildvan, D; Shonekan, D | 1 |
Bradley, JS; Scheld, WM | 1 |
Mariano, N; Rahal, JJ; Sahgal, VS; Turner, J; Urban, C; Weinbaum, F | 1 |
Noskin, GA; Peterson, LR; Ristow, TA; Warren, JR | 1 |
Dejesus, D; Dever, LL; Johanson, WG; Kaminski, ZC; Masurekar, M; Patel, D; Smith, SM | 1 |
Dever, LL; Handwerger, S | 1 |
Deobaldia, J; Evans, PA; Norden, CW; Rhoads, S; Silber, JL | 1 |
Furlong, WB; Rakowski, TA | 1 |
Bates, J; Chadwick, PR; Johnson, AP; Palepou, MF; Woodford, N | 1 |
Hardin, TC; Harkless, LB; Reyzelman, AM; Van Gils, CC; Vayser, DJ | 1 |
London, NH; Mertens, P; Stobberingh, EE; van den Bogaard, AE | 1 |
Messick, CR; Pendland, SL | 1 |
Caron, F; Eliopoulos, GM; Farris, MG; Gold, HS; Moellering, RC; Wennersten, CB | 1 |
Tuohy, M; Washington, JA | 1 |
Casewell, MW; Hill, RL; Seyed-Akhavani, M; Smith, CT | 1 |
Maskell, JP; Sefton, AM; Whiley, AC; Williams, JD | 1 |
Fernandes, F; Lorian, V | 2 |
Berthaud, N; Desnottes, JF; Diallo, N; Huet, Y | 1 |
Kramer, DJ; Linden, PK; McDevitt, D; Pasculle, AW | 1 |
Fluit, A; Heinz, HP; Jones, ME; Schmitz, FJ; Verhoef, J | 1 |
Cerwinka, S; Dowzicky, M; Eliopoulos, GM; Farris, MG; Gold, HS; Moellering, RC; Nadler, HL; Schülin, T; Souli, M; Talbot, GH; Wennersten, CB | 1 |
Busciglio, L; Fontanet, H; Gamouras, G; Larkin, J | 1 |
Huneycutt, S; Phillips, A; Tush, GM; Ward, JD | 1 |
Bompart, F; Dowzicky, M; Feger, C; Nadler, HL; Pease, M; Talbot, G | 1 |
Aeschlimann, JR; Rybak, MJ | 1 |
Aeschlimann, JR; Rybak, MJ; Zervos, MJ | 1 |
Klare, I; Werner, G; Witte, W | 1 |
Messick, CR; Pendland, SL; Woodward, J | 1 |
Matsumura, S; Simor, AE | 1 |
Heisig, P; Jones, ME; Klootwijk, M; Schmitz, FJ; Verhoef, J; Visser, MR | 1 |
Cohen, MA; Huband, MD | 1 |
Aeschlimann, JR; Hershberger, E; Moldovan, T; Rybak, MJ | 1 |
Brown, GH; Rotschafer, JC; Wright, DH | 1 |
Bompart, F; Hachem, R; Raad, I | 1 |
Andrews, J; Ashby, J; Jevons, G; Lines, N; Wise, R | 1 |
Hayashi, M; Higashitsutsumi, M; Igari, J; Inamatsu, T; Inoue, M; Kaku, M; Kanno, H; Kawai, T; Kobayashi, Y; Kohno, S; Kubo, S; Miyazaki, S; Oguri, T; Saito, A; Sakamoto, M; Shiba, K; Shimada, J; Shimizu, Y; Tokue, Y; Tomono, K; Ubukata, K; Ueda, Y; Watanabe, A; Yamaguchi, K | 1 |
Barriere, SL; Dunn, DL; Graham, DR; Kreter, B; Nichols, RL; Rodgers, A; Wilson, SE; Zervos, M | 1 |
Bozdogan, B; Leclercq, R; Lozniewski, A; Weber, M | 1 |
Péchère, JC | 1 |
Louie, L; Louie, M; Matsumura, SO; Simor, AE | 1 |
Messick, CR; Pendland, SL; Rodvold, KA | 1 |
Anholm, JD; Cheadle, WG; Fabian, TC; Fagon, J; Falcone, RE; Gibert, C; Haas, DW; Lilienthal, F; Paganin, F; Patrick, H; Torres, A | 1 |
Grucz, RG; Hershberger, E; Moldovan, T; Rybak, MJ | 1 |
Lundstrom, TS; Sobel, JD | 2 |
Barry, AL; Brown, SD; Fuchs, PC | 2 |
Flanagan, PG; Penrose-Stevens, A; Pitman, I; Simpson, BA; Tan, TY | 1 |
Chin, KG; Mactal-Haaf, C; McPherson, CE | 1 |
Murray, BE; Robredo, B; Singh, KV; Torres, C | 1 |
Foustoukou, M; Ioannidou, S; Kotsovili-Tseleni, A; Legakis, NJ; Tassios, PT; Vatopoulos, A | 1 |
Duh, RW; Malathum, K; Murray, BE; Singh, KV | 1 |
Cortés Sanchez, R; García Alberola, A; Gómez Gómez, J; López Fornas, F; Martínez García, F; Pérez Salmeron, J; Roldán Conesa, D; Ruíz Gómez, J; Valdés Chávarri, M | 1 |
Longworth, DL | 1 |
Carr, LE; English, LL; Hayes, JR; Joseph, SW; Wagner, DD | 1 |
Ferber, D | 1 |
Ameur, N; Bléton, R; Crémieux, AC; Feger, C; Ismael, F; Lemaitre, F; Massias, L; Muller-Serieys, C; Saleh-Mghir, A | 1 |
Cadrobbi, P; Cattelan, A; Cusinato, R; Gambino, A; Meneghetti, F; Narne, E; Scano, F; Sgarabotto, D; Zignol, M | 1 |
Saxén, H; Vaara, M | 1 |
Bassetti, D; Bassetti, M; Cenderello, G; Di Biagio, A; Melica, G; Rosso, R | 1 |
Rigoli, R; Scotton, PG; Vaglia, A | 1 |
García-Rodríguez, JA; Gutiérrez Zufiaurre, MN; Muñoz Bellido, JL; Sánchez Hernández, FJ; Segovia Hernández, M; Yagüe Guirao, G | 1 |
Abb, J | 1 |
Chau, F; Fantin, B; Garry, L; Leclercq, R; Lefort, A; Pavie, J; Zarrouk, V | 1 |
Moyenuddin, M; Ohl, CA; Peacock, JE; Williamson, JC | 1 |
Citron, DM; Fernandez, HT; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, YA | 1 |
Chatzidimitriou, M; Katikaridou, E; Kollaras, P; Koumentaki, E; Metallidis, S; Nikolaidis, P; Tourkantonis, A; Tsona, A | 1 |
Agamah, E; Goodrich, J; Kanchanapoom, T; Khardori, N; Koirala, J | 1 |
Clark, NM; Hershberger, E; Lynch, JP; Zervosc, MJ | 1 |
Andersen, JS; Emborg, HD; Seyfarth, AM; Wegener, HC | 1 |
Athamna, A; Athamna, M; Bast, DJ; Medlej, B; Rubinstein, E | 1 |
Ahearn, DG; Halliman, DG | 1 |
Fougnot, S; Lozniewski, A; Mory, F; Rabaud, C; Schuhmacher, H | 1 |
El-Azizi, M; Kanchanapoom, T; Khardori, N; Rao, S | 1 |
Buckley, T; Chapin, A; Gibson, K; Rule, A; Schwab, K | 1 |
Cirioni, O; De Fusco, M; Ghiselli, R; Giacometti, A; Licci, A; Mocchegiani, F; Orlando, F; Provinciali, M; Saba, V; Scalise, G; Silvestri, C | 1 |
Heo, ST; Ki, HK; Kiem, S; Ko, KS; Lee, JY; Moon, CS; Oh, WS; Peck, KR; Song, JH | 1 |
Fraser, TG; Hansen, C; Long, JK | 1 |
Chaudhury, A; Kumar, AG | 1 |
Flynn, HW; Harper, T; Miller, D | 1 |
Manfredi, R | 1 |
Chambers, HF; Hegde, SS | 1 |
Hur, JA; Kang, MW; Kim, SI; Kim, YJ; Kim, YR; Park, YJ; Wie, SH | 1 |
Batard, E; Caillon, J; Hamel, A; Jacqueline, C; Potel, G | 1 |
Anstead, GM; Lewis, JS; Quinones-Nazario, G | 1 |
De Vecchi, E; Drago, L; Nicola, L | 1 |
Bhateja, P; Bhatnagar, PK; Fatma, T; Khan, S; Mathur, T; Pandya, M; Rattan, A; Singhal, S; Upadhyay, DJ | 1 |
Manzur, A; Pujol, M; Suárez, C; Tubau, F | 1 |
Adochitei, A; Duez, JM; Neuwirth, C; Péchinot, A; Siebor, E; Sixt, N | 1 |
Alexandre, SS; Huang, V; McGowan, JE; Segal, RE; Sinner, SW; Tenover, FC; Weinstein, MP | 1 |
Ermertcan, S; Gülden, E | 1 |
Appelbaum, PC; Beachel, L; Clark, C; Dewasse, B; Kosowska-Shick, K; McGhee, P; Pankuch, GA | 1 |
Nailor, MD; Sobel, JD | 1 |
Janechek, MJ; Jones, RN; Mendes, RE; Moet, GJ | 1 |
Cheung, CM; Leuthner, KD; Rybak, MJ; Vidaillac, C | 1 |
Adali, F; Asan, A; Baltalarli, A; Cevahir, N; Kaleli, I; Onem, G; Sacar, M; Sacar, S; Susam, I; Teke, Z; Turgut, H; Yaylali, YT | 1 |
Sancak, B | 1 |
Aslantas, Ö; Demir, C; Erdem, Z; Türkyilmaz, S; Yilmaz, MA | 1 |
Arslan, U; Aydın, F; Bayramoğlu, G; Baysan, BO; Berktaş, M; Cesur, S; Cöplü, N; Demiröz, AP; Esen, B; Gencer, S; Gülay, Z; Hoşoğlu, S; Irmak, H; Karabiber, N; Kılıç, H; Simşek, H; Yalçın, AN | 1 |
Biavasco, F; Donelli, G; Pasquaroli, S; Vignaroli, C; Vuotto, C; Zandri, G | 1 |
Muscedere, J | 1 |
Hsu, AJ; Tamma, PD | 1 |
Gallagher, JC; Patel, R | 1 |
Behl, P; Chander, J; Gupta, V; Sahoo, T; Singla, N | 1 |
Bartolomeu, AR; Brito, CI; Camargo, CH; Cunha, ML; Oliveira, A; Pereira, VC; Pinheiro, L | 1 |
Ahn, JW; Baek, YS; Jeon, J; Song, HJ | 1 |
Hao, Y; Mao, R; Teng, D; Wang, J; Wang, X; Yang, N; Zong, L | 1 |
Chen, Z; Guo, Y; Li, D; Lv, J; Qi, X; Wang, L; Wang, S; Yu, F; Zhang, X | 1 |
Rybak, MJ; Smith, JR; Yim, J | 1 |
Biavasco, F; Citterio, B; Mangiaterra, G; Pasquaroli, S; Vignaroli, C | 1 |
Karahan, ZC; Ozmen Capin, BB; Tekeli, A | 1 |
Chen, YH; Chen, YS; Cheng, SH; Hsueh, PR; Ko, WC; Lee, CM; Lee, WS; Lee, YL; Liao, CH; Lin, CY; Liu, CP; Liu, PY; Lu, MC; Lu, PL; Shao, PL; Sheng, WH; Shi, ZY; Tsai, HY; Tseng, SH; Wang, FD; Wang, LS; Wu, TS; Yen, MY | 1 |
23 review(s) available for vancomycin and virginiamycin
Article | Year |
---|---|
[Synergistins, vancomycin and polymyxins].
Topics: Anti-Bacterial Agents; Humans; Polymyxins; Vancomycin; Virginiamycin | 1977 |
[Recent trend and development of novel antimicrobial agents for MRSA infections].
Topics: Daptomycin; Glycopeptides; Humans; Methicillin Resistance; Peptides; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Virginiamycin | 1992 |
Vancomycin-resistant Enterococcus faecium infections in the ICU and quinupristin/dalfopristin.
Topics: Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Vancomycin; Virginiamycin | 1996 |
The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: current antibiotic therapy in the 1990s.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Chloramphenicol; Clindamycin; Female; Fluoroquinolones; Humans; Infant; Infant, Newborn; Lactams; Male; Meningitis, Bacterial; Naphthyridines; Penicillin Resistance; Rifampin; Streptococcal Infections; Streptococcus pneumoniae; Vancomycin; Virginiamycin | 1997 |
Evaluation of in vitro activity of quinupristin/dalfopristin and comparator antimicrobial agents against worldwide clinical trial and other laboratory isolates.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clinical Trials, Phase III as Topic; Drug Resistance, Multiple; Enterococcus faecium; Gram-Positive Bacteria; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus epidermidis; Vancomycin; Virginiamycin | 1998 |
Gram-positive infections: pharmacy issues and strategy for quinupristin/dalfopristin.
Topics: Anti-Bacterial Agents; Humans; Vancomycin; Virginiamycin | 1999 |
Current and future management of infections due to methicillin-resistant staphylococci infections: the role of quinupristin/dalfopristin.
Topics: Anti-Bacterial Agents; Bacteremia; Humans; Methicillin Resistance; Staphylococcal Infections; Vancomycin; Virginiamycin | 1999 |
Antibiotics for gram-positive bacterial infections. Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazoles; Oxazolidinones; Teicoplanin; Vancomycin; Virginiamycin | 2000 |
Use of anti-infective agents during lactation: Part 1--Beta-lactam antibiotics, vancomycin, quinupristin-dalfopristin, and linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Drug Therapy, Combination; Female; Humans; Lactation; Linezolid; Milk, Human; Mothers; Oxazolidinones; Vancomycin; Virginiamycin | 2000 |
Microbial drug resistance and the roles of the new antibiotics.
Topics: Acetamides; Anti-Infective Agents; Atovaquone; Aza Compounds; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Fluoroquinolones; Gatifloxacin; Humans; Linezolid; Methicillin Resistance; Moxifloxacin; Naphthoquinones; Oxazolidinones; Proguanil; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus; Streptococcus pneumoniae; Vancomycin; Vancomycin Resistance; Virginiamycin | 2001 |
[New antibacterial agents].
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Oxazolidinones; Protein Synthesis Inhibitors; Vancomycin; Virginiamycin | 1999 |
Gram-positive bacterial resistance. A challenge for the next millennium.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacteria; Humans; Linezolid; Oxazolidinones; Staphylococcus aureus; Vancomycin; Virginiamycin | 2002 |
Antimicrobial resistance among gram-positive organisms in the intensive care unit.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Community-Acquired Infections; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Linezolid; Methicillin Resistance; Oxazolidinones; Staphylococcus aureus; Treatment Outcome; United States; Vancomycin; Virginiamycin | 2003 |
Antibiotics for gram-positive bacterial infections: vancomycin, quinupristin-dalfopristin, linezolid, and daptomycin.
Topics: Anti-Bacterial Agents; Daptomycin; Gram-Positive Bacterial Infections; Humans; Vancomycin; Virginiamycin | 2004 |
Newer antibiotics for serious gram-positive infections.
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Middle Aged; Vancomycin; Virginiamycin | 2006 |
[Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens].
Topics: Acetamides; Administration, Oral; Anti-Infective Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Practice Guidelines as Topic; Staphylococcus aureus; Streptococcus pneumoniae; Teicoplanin; Tigecycline; Time Factors; Vancomycin; Virginiamycin | 2007 |
Combating the growing problem of methicillin-resistant Staphylococcus aureus: do the newer antibiotics represent a better alternative to vancomycin?
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Staphylococcus aureus; Tigecycline; Vancomycin; Virginiamycin | 2007 |
Treatment of infections caused by resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Tigecycline; Vancomycin; Virginiamycin | 2007 |
Antibiotics for gram-positive bacterial infections: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, dalbavancin, and telavancin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Peptides, Cyclic; Teicoplanin; Vancomycin; Virginiamycin | 2009 |
[Staphylococcus aureus and antibiotic resistance].
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Protein Synthesis Inhibitors; Staphylococcal Infections; Teicoplanin; Tigecycline; Vancomycin; Vancomycin Resistance; Virginiamycin | 2011 |
Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children.
Topics: Acetamides; Adolescent; Child; Child, Preschool; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Risk Factors; Treatment Outcome; Vancomycin; Vancomycin-Resistant Enterococci; Virginiamycin | 2014 |
Vancomycin-resistant enterococcal bacteremia pharmacotherapy.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Vancomycin; Vancomycin-Resistant Enterococci; Virginiamycin | 2015 |
Role of Combination Antimicrobial Therapy for Vancomycin-Resistant Enterococcus faecium Infections: Review of the Current Evidence.
Topics: Animals; Anti-Bacterial Agents; Cross Infection; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Teicoplanin; Vancomycin; Vancomycin Resistance; Virginiamycin | 2017 |
5 trial(s) available for vancomycin and virginiamycin
Article | Year |
---|---|
Treatment of vancomycin-resistant Enterococcus faecium infections with an investigational streptogramin antibiotic (quinupristin/dalfopristin): a report of fifteen cases.
Topics: Adult; Aged; Anti-Bacterial Agents; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Enterococcus faecium; Female; Gram-Negative Bacterial Infections; Humans; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Vancomycin; Virginiamycin | 1996 |
Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: comparison with a control cohort.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Drug Resistance, Microbial; Enterococcus faecium; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Treatment Outcome; Vancomycin; Virginiamycin | 1997 |
Prospective, randomized dose-ranging open phase II pilot study of quinupristin/dalfopristin versus vancomycin in the treatment of catheter-related staphylococcal bacteremia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Catheterization; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies; Single-Blind Method; Staphylococcal Infections; Vancomycin; Virginiamycin | 1999 |
Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection Gr
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitalization; Humans; Male; Middle Aged; Oxacillin; Penicillins; Skin Diseases, Bacterial; Vancomycin; Virginiamycin | 1999 |
Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group.
Topics: Adult; Aged; Anti-Bacterial Agents; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia, Pneumococcal; Pneumonia, Staphylococcal; Prospective Studies; Treatment Outcome; Vancomycin; Virginiamycin | 2000 |
118 other study(ies) available for vancomycin and virginiamycin
Article | Year |
---|---|
Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Quinolones; Streptococcus pneumoniae; Vancomycin; Virginiamycin | 1992 |
Pristinamycin for Enterococcus faecium resistant to vancomycin and gentamicin.
Topics: Child; Drug Resistance, Microbial; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin; Virginiamycin | 1992 |
Studies of RP 59500 in vitro and in a rabbit model of aortic valve endocarditis caused by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Aortic Valve; Drug Combinations; Drug Resistance, Microbial; Endocarditis, Bacterial; Heart Valve Diseases; In Vitro Techniques; Methicillin; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin | 1992 |
The in-vitro activity of RP 59500 against gram-positive cocci.
Topics: Amoxicillin; Ciprofloxacin; Erythromycin; Gram-Positive Cocci; In Vitro Techniques; Josamycin; Methicillin Resistance; Microbial Sensitivity Tests; Vancomycin; Virginiamycin | 1992 |
Comparative in-vitro activity of RP 59500.
Topics: Bacteria; Ciprofloxacin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Gentamicins; In Vitro Techniques; Microbial Sensitivity Tests; Oxacillin; Vancomycin; Virginiamycin | 1992 |
Comparative efficacy of pefloxacin and six other antimicrobial agents on Staphylococcus aureus experimental abscesses.
Topics: Abscess; Administration, Oral; Animals; Anti-Bacterial Agents; Cephalothin; Ciprofloxacin; Injections, Subcutaneous; Methicillin; Mice; Norfloxacin; Pefloxacin; Penicillin Resistance; Peptides; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Thigh; Vancomycin; Virginiamycin | 1986 |
In-vitro susceptibility of oral streptococci to pristinamycin.
Topics: Amoxicillin; Anti-Bacterial Agents; Erythromycin; Humans; Microbial Sensitivity Tests; Mouth; Peptides; Streptococcus; Vancomycin; Virginiamycin | 1987 |
[Corynebacterium group D2. Clinical study, biochemical identification and antibiotic sensitivity].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Corynebacterium; Corynebacterium Infections; Drug Resistance, Microbial; Enoxacin; Female; Humans; Male; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Peptides, Cyclic; Pipemidic Acid; Rifampin; Tetracycline; Tetracycline Resistance; Urinary Tract Infections; Vancomycin; Virginiamycin | 1988 |
Comparative in-vitro activity of erythromycin, vancomycin and pristinamycin.
Topics: Bacteria; Enterobacteriaceae; Erythromycin; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus; Vancomycin; Virginiamycin | 1988 |
[New antibiotics, with the exception of penicillins, streptomycin, tetracyclines and chloramphenicol].
Topics: Anti-Bacterial Agents; Cephalosporins; Chemistry, Pharmaceutical; Erythromycin; Fusidic Acid; Gentamicins; Kanamycin; Leucomycins; Lincomycin; Neomycin; Novobiocin; Oleandomycin; Paromomycin; Polymyxins; Rifampin; Ristocetin; Spectinomycin; Vancomycin; Virginiamycin | 1968 |
[Sensitivity of staphylococci to antibiotics].
Topics: Ampicillin; Anti-Bacterial Agents; Cephalothin; Chloramphenicol; Chlortetracycline; Culture Media; Erythromycin; Kanamycin; Methicillin; Oxytetracycline; Penicillin G; Penicillin Resistance; Rifampin; Staphylococcus; Streptomycin; Vancomycin; Virginiamycin | 1966 |
[In vitro study of strains of Staphylococcus: choice of an antibiotic].
Topics: Anti-Bacterial Agents; Cephalothin; Drug Resistance, Microbial; Fosfomycin; Microbial Sensitivity Tests; Staphylococcus; Staphylococcus aureus; Vancomycin; Virginiamycin | 1984 |
Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500.
Topics: Animals; Drug Resistance, Microbial; Endocarditis, Bacterial; Erythromycin; Female; Methicillin Resistance; Microbial Sensitivity Tests; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin | 1995 |
RP 59500 prophylaxis of experimental endocarditis due to erythromycin-susceptible and -resistant isogenic pairs of viridans group streptococci.
Topics: Animals; Conjugation, Genetic; Drug Resistance, Microbial; Endocarditis, Bacterial; Erythromycin; Female; Microbial Sensitivity Tests; Rats; Rats, Wistar; Streptococcal Infections; Streptococcus; Vancomycin; Virginiamycin | 1995 |
Pharmacodynamics of RP 59500 alone and in combination with vancomycin against Staphylococcus aureus in an in vitro-infected fibrin clot model.
Topics: Blood Coagulation; Drug Therapy, Combination; Fibrin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Thrombosis; Vancomycin; Virginiamycin | 1995 |
Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 (quinupristin-dalfopristin) in experimental endocarditis due to Staphylococcus aureus.
Topics: Animals; Drug Resistance, Microbial; Endocarditis, Bacterial; Female; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin | 1995 |
In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Depsipeptides; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Fusidic Acid; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Novobiocin; Peptides, Cyclic; Quinolones; Teicoplanin; Vancomycin; Virginiamycin | 1995 |
Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology.
Topics: Anti-Infective Agents; Ciprofloxacin; Erythromycin; Fluoroquinolones; Kinetics; Microbial Sensitivity Tests; Penicillin G; Quinolones; Streptococcus pneumoniae; Time Factors; Vancomycin; Virginiamycin | 1994 |
In vivo activities and penetration of the two components of the streptogramin RP 59500 in cardiac vegetations of experimental endocarditis.
Topics: Animals; Autoradiography; Culture Media; Drug Synergism; Endocarditis, Bacterial; Female; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus sanguis; Vancomycin; Virginiamycin | 1994 |
In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms.
Topics: Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Vancomycin; Virginiamycin | 1993 |
Bactericidal activity and kinetics of RP 59500 in a mouse model of Staphylococcus aureus septicaemia.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Serum Bactericidal Test; Software; Staphylococcal Infections; Vancomycin; Virginiamycin | 1995 |
Selection of Enterococcus faecium strains with stable and unstable resistance to the streptogramin RP 59500 using stepwise in vitro exposure.
Topics: Anti-Bacterial Agents; Culture Media; Drug Resistance, Microbial; Enterococcus faecium; Microbial Sensitivity Tests; Vancomycin; Virginiamycin | 1996 |
Intracellular activities of RP 59500 (quinupristin-dalfopristin) and sparfloxacin against Enterococcus faecium.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Enterococcus faecium; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Neutrophils; Quinolones; Vancomycin; Virginiamycin | 1996 |
In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci.
Topics: Anti-Bacterial Agents; Enterococcus; Glycopeptides; Lipoglycopeptides; Microbial Sensitivity Tests; Staphylococcus; Teicoplanin; Vancomycin; Virginiamycin | 1996 |
Activity of the quinupristin-dalfopristin combination (RP-59500; Synercid) tested against vancomycin-resistant Enterococcus species.
Topics: Anti-Bacterial Agents; Drug Combinations; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Vancomycin; Virginiamycin | 1996 |
Emergence of increased resistance to quinupristin/dalfopristin during therapy for Enterococcus faecium bacteremia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Drug Resistance, Multiple; Echocardiography; Enterococcus faecium; Gram-Positive Bacterial Infections; HIV Infections; Humans; Male; Microbial Sensitivity Tests; Vancomycin; Virginiamycin | 1997 |
Superinfection with Enterococcus faecalis during quinupristin/dalfopristin therapy.
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Coronary Artery Bypass; Diabetes Mellitus, Type 1; Drug Hypersensitivity; Endocarditis; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Humans; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Penicillins; Renal Dialysis; Staphylococcal Infections; Staphylococcus aureus; Superinfection; Vancomycin; Virginiamycin; Wound Infection | 1997 |
In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Bacteremia; Catheterization, Central Venous; Cefamandole; Cephalosporins; Ciprofloxacin; Clindamycin; Daptomycin; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Neoplasms; Novobiocin; Oxacillin; Penicillins; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Vancomycin; Virginiamycin | 1996 |
Comparative in-vitro activities of RP59500 (quinupristin/dalfopristin), CL 329,998, CL 331,002, trovafloxacin, clinafloxacin, teicoplanin and vancomycin against Gram-positive bacteria.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Quinolones; Teicoplanin; Tetracyclines; Vancomycin; Virginiamycin | 1997 |
Quinupristin/dalfopristin (RP 59500) therapy for vancomycin-resistant Enterococcus faecium aortic graft infection: case report.
Topics: Anti-Bacterial Agents; Arteries; Coronary Artery Bypass; Drug Resistance, Microbial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Middle Aged; Postoperative Complications; Vancomycin; Virginiamycin | 1995 |
In vitro activity of RP 59500 (quinupristin/dalfopristin) and ramoplanin against vancomycin-resistant Enterococcus faecium.
Topics: Anti-Bacterial Agents; Colony Count, Microbial; Depsipeptides; Drug Resistance, Microbial; Enterococcus faecium; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Kinetics; Microbial Sensitivity Tests; Peptides, Cyclic; Phenotype; Vancomycin; Virginiamycin | 1995 |
Persistence of vancomycin-resistant Enterococcus faecium gastrointestinal tract colonization in antibiotic-treated mice.
Topics: Animals; Anti-Bacterial Agents; Biliary Tract; Colony Count, Microbial; Digestive System; Drug Resistance, Microbial; Enterococcus faecium; Feces; Female; Liver; Mice; Vancomycin; Virginiamycin | 1996 |
In vitro susceptibilities of clinical isolates of vancomycin-resistant enterococci.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Microbial Sensitivity Tests; Penicillins; Vancomycin; Virginiamycin | 1997 |
Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to enterococci with VanA/VanB resistance patterns.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Endocarditis, Bacterial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Middle Aged; Prosthesis-Related Infections; Vancomycin; Virginiamycin | 1997 |
Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
Topics: Animals; Anti-Bacterial Agents; Chickens; Drug Resistance, Microbial; Enterococcus; Humans; Microbial Sensitivity Tests; Vancomycin; Virginiamycin | 1997 |
Vancomycin-resistant enterococci osteomyelitis in the foot. A case report.
Topics: Aged; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Humans; Male; Osteomyelitis; Tarsal Bones; Vancomycin; Virginiamycin | 1997 |
High prevalence of colonization with vancomycin- and pristinamycin-resistant enterococci in healthy humans and pigs in The Netherlands: is the addition of antibiotics to animal feeds to blame?
Topics: Animal Feed; Animals; Drug Resistance, Microbial; Enterococcus; Feces; Humans; Microbial Sensitivity Tests; Netherlands; Vancomycin; Virginiamycin | 1997 |
In vitro activity of chloramphenicol alone and in combination with vancomycin, ampicillin, or RP 59500 (quinupristin/dalfopristin) against vancomycin-resistant enterococci.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Cross Infection; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins; Vancomycin; Virginiamycin | 1997 |
Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP 59500 (quinupristin-dalfopristin) against vancomycin-resistant Enterococcus faecium.
Topics: Anti-Bacterial Agents; Cell Cycle; Drug Resistance, Microbial; Enterococcus faecium; Erythromycin; Microbial Sensitivity Tests; Time Factors; Vancomycin; Virginiamycin | 1997 |
Antimicrobial susceptibility of viridans group streptococci.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Clindamycin; Drug Resistance, Microbial; Gentamicins; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rifampin; Streptococcal Infections; Streptococcus; Thienamycins; Vancomycin; Virginiamycin | 1997 |
Bactericidal and inhibitory activity of quinupristin/dalfopristin against vancomycin- and gentamicin-resistant Enterococcus faecium.
Topics: Anti-Bacterial Agents; Colony Count, Microbial; Drug Resistance, Multiple; Enterococcus faecium; Gentamicins; Humans; Microbial Sensitivity Tests; Vancomycin; Virginiamycin | 1997 |
In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Colony Count, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enterococcus; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Time Factors; Vancomycin; Virginiamycin | 1997 |
Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp.
Topics: Amoxicillin; Anti-Bacterial Agents; Enterococcus; Erythromycin; Humans; Microbial Sensitivity Tests; Teicoplanin; Vancomycin; Virginiamycin | 1997 |
Synergic activity of vancomycin-quinupristin/dalfopristin combination against Enterococcus faecium.
Topics: Colony Count, Microbial; Drug Synergism; Drug Therapy, Combination; Enterococcus faecium; Humans; Microbial Sensitivity Tests; Vancomycin; Virginiamycin | 1997 |
Antistaphylococcal activities of quinupristin/dalfopristin in vitro across platelet-fibrin matrices and in experimental endocarditis.
Topics: Animals; Anti-Bacterial Agents; Blood Platelets; Colony Count, Microbial; Endocarditis, Bacterial; Male; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcus aureus; Vancomycin; Virginiamycin | 1997 |
Stability of the MICs of various antibiotics in different clonal populations of methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Fluoroquinolones; Germany; Hospitals; Humans; Longitudinal Studies; Methicillin Resistance; Microbial Sensitivity Tests; Minocycline; Staphylococcus aureus; Teicoplanin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Virginiamycin | 1998 |
Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecium; Humans; Microbial Sensitivity Tests; United States; Vancomycin; Virginiamycin | 1998 |
Staphylococcus epidermidis endocarditis treated with RP 59500 (quinapristin/dalfopristin).
Topics: Adult; Anti-Bacterial Agents; Endocarditis, Bacterial; Humans; Male; Methicillin Resistance; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin; Virginiamycin | 1998 |
Intraventricular quinupristin/dalfopristin for the treatment of vancomycin-resistant Enterococcus faecium shunt infection.
Topics: Adult; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Injections, Intraventricular; Male; Vancomycin; Ventriculoperitoneal Shunt; Virginiamycin | 1998 |
Effect of quinupristin/dalfopristin alone or in combination with vancomycin on the structure of Enterococcus faecium.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecium; Microbial Sensitivity Tests; Microscopy, Electron; Vancomycin; Virginiamycin | 1998 |
Pharmacodynamic analysis of the activity of quinupristin-dalfopristin against vancomycin-resistant Enterococcus faecium with differing MBCs via time-kill-curve and postantibiotic effect methods.
Topics: Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecium; Microbial Sensitivity Tests; Vancomycin; Virginiamycin | 1998 |
Treatment of vancomycin-resistant Enterococcus faecium with RP 59500 (quinupristin-dalfopristin) administered by intermittent or continuous infusion, alone or in combination with doxycycline, in an in vitro pharmacodynamic infection model with simulated e
Topics: Anti-Bacterial Agents; Doxycycline; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecium; Humans; Microbial Sensitivity Tests; Vancomycin; Virginiamycin | 1998 |
Association between quinupristin/dalfopristin resistance in glycopeptide-resistant Enterococcus faecium and the use of additives in animal feed.
Topics: Animal Feed; Animals; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus faecium; Food Additives; Meat; Meat Products; Vancomycin; Virginiamycin | 1998 |
Postantibiotic effect and postantibiotic sub-MIC effect of quinupristin-dalfopristin against gram-positive and -negative organisms.
Topics: Anti-Bacterial Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Vancomycin; Virginiamycin | 1998 |
In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococci.
Topics: Ampicillin; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin; Virginiamycin | 1998 |
Treatment of endocarditis due to vancomycin-resistant Enterococcus faecium with quinupristin/dalfopristin, doxycycline, and rifampin: a synergistic drug combination.
Topics: Aged; Doxycycline; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Male; Rifampin; Vancomycin; Virginiamycin | 1998 |
Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-re
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gentamicins; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolines; Quinolones; Staphylococcus aureus; Vancomycin; Virginiamycin | 1999 |
Activity of clinafloxacin, trovafloxacin, quinupristin/dalfopristin, and other antimicrobial agents versus Staphylococcus aureus isolates with reduced susceptibility to vancomycin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Staphylococcus aureus; Vancomycin; Virginiamycin | 1999 |
Evaluation of bactericidal activities of LY333328, vancomycin, teicoplanin, ampicillin-sulbactam, trovafloxacin, and RP59500 alone or in combination with rifampin or gentamicin against different strains of vancomycin-intermediate Staphylococcus aureus by
Topics: Ampicillin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Drug Therapy, Combination; Fluoroquinolones; Gentamicins; Glycopeptides; Lipoglycopeptides; Microbial Sensitivity Tests; Naphthyridines; Rifampin; Staphylococcus aureus; Sulbactam; Teicoplanin; Time Factors; Vancomycin; Virginiamycin | 1999 |
Antimicrobial resistance in gram-positive pathogens isolated in the UK between October 1996 and January 1997.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Environmental Monitoring; Gram-Positive Bacteria; Hospitals; Humans; Microbial Sensitivity Tests; Staphylococcus; Streptococcus pneumoniae; United Kingdom; Vancomycin; Virginiamycin | 1999 |
[Susceptibilities of Enterococcus faecium, PRSP and MRSA to RP59500 and their correlations with those to other drugs].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Enterococcus faecium; Humans; Methicillin Resistance; Penicillin Resistance; Staphylococcus aureus; Streptococcus pneumoniae; Vancomycin; Virginiamycin | 1999 |
Plasmid-mediated coresistance to streptogramins and vancomycin in Enterococcus faecium HM1032.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple; Enterococcus faecium; Humans; Plasmids; Vancomycin; Virginiamycin | 1999 |
Synergy testing of vancomycin-resistant Enterococcus faecium against quinupristin-dalfopristin in combination with other antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Drug Synergism; Enterococcus faecium; Genotype; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Time Factors; Vancomycin; Vancomycin Resistance; Virginiamycin | 1999 |
Modified time-kill assay against multidrug-resistant Enterococcus faecium with novel antimicrobial combinations.
Topics: Ampicillin; Chloramphenicol; Colony Count, Microbial; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enterococcus faecium; Gentamicins; Kinetics; Microbial Sensitivity Tests; Time Factors; Vancomycin; Virginiamycin | 1999 |
In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple; Enterococcus; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Staphylococcus; Time Factors; Vancomycin; Virginiamycin | 2000 |
Bactericidal activity of quinupristin-dalfopristin against Staphylococcus aureus: clindamycin susceptibility as a surrogate indicator.
Topics: Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Drug Therapy, Combination; Microbial Sensitivity Tests; Phenotype; Staphylococcus aureus; Time Factors; Vancomycin; Virginiamycin | 2000 |
Treatment of a vancomycin-resistant Enterococcus faecium ventricular drain infection with quinupristin/dalfopristin and review of the literature.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enterococcus faecium; Fatal Outcome; Female; Gram-Positive Bacterial Infections; Humans; Hydrocephalus; Injections, Intravenous; Injections, Intraventricular; Injections, Spinal; Linezolid; Middle Aged; Oxazoles; Oxazolidinones; Subarachnoid Hemorrhage; Tomography, X-Ray Computed; Vancomycin; Ventriculoperitoneal Shunt; Virginiamycin | 2000 |
Streptogramin resistance and shared pulsed-field gel electrophoresis patterns in vanA-containing Enterococcus faecium and Enterococcus hirae isolated from humans and animals in Spain.
Topics: Acetyltransferases; Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Chickens; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Enterococcus faecium; Feces; Humans; Microbial Sensitivity Tests; Spain; Vancomycin; Virginiamycin | 2000 |
Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Child; Child, Preschool; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Female; Fluoroquinolones; Greece; Humans; Infant; Male; Microbial Sensitivity Tests; Oropharynx; Phenotype; Rifampin; Streptococcus; Tetracycline; Vancomycin; Virginiamycin | 2001 |
In vitro activity of 19 antimicrobial agents against enterococci from healthy subjects and hospitalized patients and use of an ace gene probe from Enterococcus faecalis for species identification.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus faecalis; Feces; Genes, Bacterial; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Probes; Species Specificity; Vancomycin; Virginiamycin | 2001 |
Comparative study of treatment with penicillin, ceftriaxone, trovafloxacin, quinupristin-dalfopristin and vancomycin in experimental endocarditis due to penicillin- and ceftriaxone-resistant Streptococcus pneumoniae.
Topics: Animals; Anti-Infective Agents; Ceftriaxone; Disease Models, Animal; Drug Resistance, Multiple; Endocarditis, Bacterial; Fluoroquinolones; Humans; Male; Naphthyridines; Penicillin Resistance; Penicillins; Pneumococcal Infections; Rabbits; Streptococcus pneumoniae; Vancomycin; Virginiamycin | 2001 |
Implications of multiple antimicrobial-resistant enterococci associated with the poultry environment.
Topics: Animals; Drug Resistance, Multiple, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Feces; Food Microbiology; Gentamicins; Penicillins; Poultry; Streptomycin; United States; Vancomycin; Virginiamycin | 2001 |
Antibiotic resistance. Livestock feed ban preserves drugs' power.
Topics: Animal Feed; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Chickens; Drug Resistance, Bacterial; Enrofloxacin; Enterococcus; Europe; Feces; Fluoroquinolones; Glycopeptides; Humans; Quinolones; Swine; United States; United States Food and Drug Administration; Vancomycin; Vancomycin Resistance; Virginiamycin | 2002 |
In vitro bactericidal activity of daptomycin against staphylococci.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Therapy, Combination; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus; Vancomycin; Virginiamycin | 2002 |
Combination of quinupristin-dalfopristin (Synercid) and rifampin is highly synergistic in experimental Staphylococcus aureus joint prosthesis infection.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Drug Synergism; Drug Therapy, Combination; Joint Prosthesis; Methicillin Resistance; Prosthesis-Related Infections; Rabbits; Rifampin; Staphylococcal Infections; Tissue Distribution; Vancomycin; Virginiamycin | 2002 |
Synercid plus vancomycin for the treatment of severe methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci infections: evaluation of 5 cases.
Topics: Abdominal Abscess; Adult; Aged; Anti-Bacterial Agents; Coagulase; Drug Therapy, Combination; Endocarditis; Female; Heart-Assist Devices; Humans; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin | 2002 |
Combination of quinupristin/dalfopristin and glycopeptide in severe methicillin-resistant staphylococcal infections failing previous glycopeptide regimens.
Topics: Adult; Aged; Anti-Bacterial Agents; Colony Count, Microbial; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Sampling Studies; Sensitivity and Specificity; Severity of Illness Index; Staphylococcal Infections; Teicoplanin; Treatment Outcome; Vancomycin; Virginiamycin | 2002 |
In vitro activity of linezolid, synercid and telithromycin against genetically defined high level fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Resistance, Multiple; In Vitro Techniques; Ketolides; Linezolid; Macrolides; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Vancomycin; Virginiamycin | 2002 |
In vitro activity of linezolid, quinupristin-dalfopristin, vancomycin, teicoplanin, moxifloxacin and mupirocin against methicillin-resistant Staphylococcus aureus: comparative evaluation by the E test and a broth microdilution method.
Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Mupirocin; Oxazolidinones; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Virginiamycin | 2002 |
Efficacies of quinupristin-dalfopristin combined with vancomycin in vitro and in experimental endocarditis due to methicillin-resistant Staphylococcus aureus in relation to cross-resistance to macrolides, lincosamides, and streptogramin B- type antibiotic
Topics: Animals; Anti-Bacterial Agents; Culture Media; Drug Resistance; Drug Therapy, Combination; Endocarditis, Bacterial; Lincosamides; Macrolides; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcus aureus; Streptogramin B; Time Factors; Vancomycin; Virginiamycin | 2002 |
Disseminated oxacillin-resistant Staphylococcus aureus infection responsive to vancomycin and quinupristin-dalfopristin combination therapy.
Topics: Aged; Drug Therapy, Combination; Female; Humans; Oxacillin; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin | 2003 |
In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates.
Topics: Acetamides; Anti-Bacterial Agents; Corynebacterium; Daptomycin; Gram-Positive Bacteria; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Vancomycin; Virginiamycin | 2003 |
Comparative in vitro activity of quinupristin/dalfopristin and seven other antimicrobials against methicillin-susceptible and methicillin-resistant nosocomial Staphylococcus aureus bloodstream isolates.
Topics: Anti-Bacterial Agents; Bacteremia; Clindamycin; Cross Infection; Erythromycin; Gentamicins; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Virginiamycin | 2002 |
Treatment of central nervous system infection by vancomycin-resistant enterococcus faecium.
Topics: Aged; Brain Neoplasms; Central Nervous System Infections; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterococcus faecium; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Injections, Intralesional; Lymphoma; Male; Opportunistic Infections; Risk Assessment; Treatment Outcome; Vancomycin; Virginiamycin | 2003 |
Relations between the consumption of antimicrobial growth promoters and the occurrence of resistance among Enterococcus faecium isolated from broilers.
Topics: Animal Feed; Animal Husbandry; Animals; Anti-Bacterial Agents; Chickens; Denmark; Drug Administration Schedule; Drug Resistance, Bacterial; Enterococcus faecium; Erythromycin; Gram-Positive Bacterial Infections; Linear Models; Logistic Models; Markov Chains; Microbial Sensitivity Tests; Monte Carlo Method; Oligosaccharides; Poultry Diseases; Time Factors; Vancomycin; Virginiamycin | 2004 |
In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis.
Topics: Acetamides; Anti-Bacterial Agents; Bacillus anthracis; beta-Lactams; Chloramphenicol; Clindamycin; Fluoroquinolones; Linezolid; Macrolides; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Tetracyclines; Vancomycin; Virginiamycin | 2004 |
Relative susceptibilities to vancomycin and quinupristin-dalfopristin of adhered and planktonic vancomycin-resistant and vancomycin-susceptible coagulase-negative staphylococci.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Catheterization; Coagulase; Drug Resistance, Bacterial; Hydrogels; Methicillin Resistance; Microbial Sensitivity Tests; Silicones; Staphylococcus; Vancomycin; Vancomycin Resistance; Virginiamycin | 2004 |
In vitro activities of cefotaxime, vancomycin, quinupristin/dalfopristin, linezolid and other antibiotics alone and in combination against Propionibacterium acnes isolates from central nervous system infections.
Topics: Acetamides; Cefotaxime; Central Nervous System Infections; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Propionibacterium acnes; Vancomycin; Virginiamycin | 2005 |
In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci.
Topics: Acetamides; Biofilms; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin; Virginiamycin | 2005 |
Airborne multidrug-resistant bacteria isolated from a concentrated swine feeding operation.
Topics: Air Microbiology; Animal Husbandry; Animals; Anti-Bacterial Agents; Clindamycin; Drug Resistance, Bacterial; Enterococcus; Environmental Monitoring; Erythromycin; Inhalation Exposure; Microbial Sensitivity Tests; Mid-Atlantic Region; Staphylococcus; Swine; Tetracycline; Vancomycin; Virginiamycin; Viridans Streptococci | 2005 |
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Catheters, Indwelling; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Linezolid; Male; Oxazolidinones; Plankton; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Virginiamycin | 2005 |
Synergy of arbekacin-based combinations against vancomycin hetero-intermediate Staphylococcus aureus.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Bacterial; Drug Synergism; Humans; In Vitro Techniques; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Teicoplanin; Vancomycin; Virginiamycin | 2006 |
In vitro activity of antimicrobial agents against oxacillin resistant staphylococci with special reference to Staphylococcus haemolyticus.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; India; Linezolid; Microbial Sensitivity Tests; Oxacillin; Oxazolidinones; Staphylococcus; Staphylococcus haemolyticus; Teicoplanin; Vancomycin; Virginiamycin | 2007 |
In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates.
Topics: Acetamides; Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Biological Availability; Coagulase; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Microbiological Techniques; Moxifloxacin; Oxazolidinones; Quinolines; Staphylococcal Infections; Staphylococcus; Vancomycin; Virginiamycin | 2007 |
Comparison of the MicroScan system and the agar dilution assay for Quinupristin/Dalfopristin susceptibility of Enterococcus faecium.
Topics: Anti-Bacterial Agents; Colony Count, Microbial; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Reproducibility of Results; Teicoplanin; Vancomycin; Virginiamycin | 2007 |
Efficacy of quinupristin/dalfopristin versus vancomycin, alone or in combination with rifampicin, against methicillin-resistant Staphylococcus aureus in a rabbit arthritis model.
Topics: Animals; Anti-Bacterial Agents; Arthritis, Infectious; Disease Models, Animal; Drug Therapy, Combination; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin | 2008 |
A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
Topics: Acetamides; Anti-Bacterial Agents; Colony Count, Microbial; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Oxazolidinones; Selection, Genetic; Staphylococcus aureus; Teicoplanin; Vancomycin; Virginiamycin | 2008 |
Effect of oxazolidinone, RBx 7644 (ranbezolid), on inhibition of staphylococcal adherence to plastic surfaces.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Dose-Response Relationship, Drug; Furans; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Plastics; Staphylococcus aureus; Staphylococcus epidermidis; Time Factors; Vancomycin; Virginiamycin | 2008 |
[Persistent bacteremia caused by methicillin-resistant Staphylococcus aureus].
Topics: Aged; Bacteremia; Catheterization, Central Venous; Chronic Disease; Daptomycin; Discitis; Humans; Jugular Veins; Male; Methicillin-Resistant Staphylococcus aureus; Pancreatitis; Rifampin; Staphylococcal Infections; Vancomycin; Virginiamycin | 2008 |
In vitro combinations of five intravenous antibiotics with dalfopristin-quinupristin against Staphylococcus aureus in a 3-dimensional model.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Fosfomycin; Gentamicins; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Rifampin; Staphylococcus aureus; Tigecycline; Vancomycin; Virginiamycin | 2008 |
Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapy.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Resistance, Bacterial; Endocarditis, Bacterial; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Virginiamycin | 2009 |
[In vitro activities of quinupristin/dalfopristin in combination with vancomycin and gatifloxacin against Staphylococcus aureus and Enterococcus faecium clinical isolates].
Topics: Anti-Bacterial Agents; Drug Combinations; Drug Synergism; Enterococcus faecium; Fluoroquinolones; Gatifloxacin; Humans; Staphylococcus aureus; Vancomycin; Virginiamycin | 2009 |
Activity of telavancin against staphylococci and enterococci determined by MIC and resistance selection studies.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Enterococcus; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Point Mutation; Staphylococcus; Vancomycin; Virginiamycin | 2009 |
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Linezolid; Lipoglycopeptides; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin | 2010 |
In vitro activity of the new multivalent glycopeptide-cephalosporin antibiotic TD-1792 against vancomycin-nonsusceptible Staphylococcus isolates.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Daptomycin; Glycopeptides; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus; Staphylococcus aureus; Vancomycin; Vancomycin Resistance; Virginiamycin | 2010 |
Comparison of antimicrobial agents as therapy for experimental endocarditis: caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Animals; Anti-Infective Agents; Aortic Valve; Colony Count, Microbial; Disease Models, Animal; Endocarditis, Bacterial; Infusions, Intravenous; Injections, Intravenous; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Rats; Rats, Wistar; Teicoplanin; Time Factors; Vancomycin; Virginiamycin | 2010 |
Isolation and molecular characterization of methicillin-resistant staphylococci from horses, personnel and environmental sites at an equine hospital in Turkey.
Topics: Animal Technicians; Animals; Cross Infection; DNA Primers; Electrophoresis, Gel, Pulsed-Field; Genes, MDR; Horse Diseases; Horses; Humans; Methicillin Resistance; Polymerase Chain Reaction; Rifampin; Species Specificity; Staphylococcal Infections; Staphylococcus; Turkey; Vancomycin; Virginiamycin | 2012 |
[Evaluation of antibiotic susceptibilities and VISA-VRSA rates among MRSA strains isolated from hospitalized patients in intensive care units of hospitals in seven provinces of Turkey].
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Intensive Care Units; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Turkey; Vancomycin; Vancomycin Resistance; Virginiamycin | 2012 |
Antibiotic pressure can induce the viable but non-culturable state in Staphylococcus aureus growing in biofilms.
Topics: Anti-Bacterial Agents; Bacterial Load; Biofilms; Cytokinesis; Gene Expression Profiling; Microbial Viability; Staphylococcus aureus; Vancomycin; Virginiamycin | 2013 |
Which antibiotic for hospital acquired pneumonia caused by MRSA?
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Pneumonia, Staphylococcal; Tigecycline; Vancomycin; Virginiamycin | 2014 |
Antimicrobial susceptibility pattern of vancomycin resistant enterococci to newer antimicrobial agents.
Topics: Anti-Infective Agents; Daptomycin; Humans; Linezolid; Minocycline; Tigecycline; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Virginiamycin | 2015 |
Susceptibility Profile of Staphylococcus epidermidis and Staphylococcus haemolyticus Isolated from Blood Cultures to Vancomycin and Novel Antimicrobial Drugs over a Period of 12 Years.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Blood Culture; Brazil; Daptomycin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Hospitals, Teaching; Humans; Linezolid; Minocycline; Mutation; Oxacillin; Prevalence; Staphylococcal Infections; Staphylococcus epidermidis; Staphylococcus haemolyticus; Tigecycline; Vancomycin; Virginiamycin | 2016 |
Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Dibekacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fusidic Acid; Gentamicins; Humans; Infant; Infant, Newborn; Ketolides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Oxacillin; Republic of Korea; Retrospective Studies; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Tetracycline; Vancomycin; Virginiamycin; Young Adult | 2016 |
Mechanism of action of a novel recombinant peptide, MP1102, against Clostridium perfringens type C.
Topics: Ampicillin; Anti-Bacterial Agents; Cell Membrane; Chlortetracycline; Clostridium perfringens; DNA, Bacterial; Drug Synergism; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Nisin; Recombinant Proteins; Temperature; Vancomycin; Virginiamycin; Zinc | 2016 |
Characteristic of Enterococcus faecium clinical isolates with quinupristin/dalfopristin resistance in China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; China; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Prevalence; RNA, Ribosomal, 16S; Vancomycin; Virginiamycin | 2016 |
Influence of sublethal concentrations of vancomycin and quinupristin/dalfopristin on the persistence of viable but non-culturable Staphylococcus aureus growing in biofilms.
Topics: Anti-Bacterial Agents; Bacterial Load; Biofilms; Gene Expression Profiling; Microbial Viability; Staphylococcus aureus; Vancomycin; Virginiamycin | 2018 |
Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Ceftaroline; Cephalosporins; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Genes, Bacterial; Humans; Linezolid; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phylogeny; Rifampin; Staphylococcal Infections; Tetracycline; Turkey; Vancomycin; Vancomycin Resistance; Virginiamycin | 2020 |
Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019-2020 Nationwide Surveillance of Multicenter Antimicrobial Resist
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Resistance, Bacterial; Enterococcus faecium; Epidemiological Monitoring; Gram-Positive Bacterial Infections; Humans; Linezolid; Lipoglycopeptides; Microbial Sensitivity Tests; Oxazolidinones; Taiwan; Tetracyclines; Tetrazoles; Tigecycline; Vancomycin; Vancomycin-Resistant Enterococci; Virginiamycin | 2021 |